Sveriges mest populära poddar
eanCast: Weekly Neurology
Hälsa och motionMedicin

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

24 min•18 augusti 2024
Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Thomas Berger (Vienna, Austria) Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.

Fler avsnitt av eanCast: Weekly Neurology

Visa alla avsnitt av eanCast: Weekly Neurology
Ep. 195: Functional Neurological Disorder Across Europe: Bridging Gaps in Neurology Training and Clinical Practice
•28 min
Ep. 194: Autism in children and adults: different or the same?
•49 min
Ep. 193: Understanding GBS and other inflammatory neuropathies across ages
•28 min
Ep. 192: Movement disorders in children and adults: different or the same?
•36 min
Ep. 191: FND in children and adults: different or the same?
•39 min
Ep. 190: Parkinson’s disease – more than a movement disorder
•20 min
Ep. 189: Red flags of treatable (spino)cerebellar ataxias
•46 min
Ep. 188: Red flags of treatable rare myopathies
•33 min
Ep. 187: Red flags of treatable rare cerebral small vessels diseases
•20 min
Ep. 186: Red flags of treatable mitochondrial disorders
•26 min

eanCast: Weekly Neurology med ean.org finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.